Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

Abstract

A single dose of TCV was immunogenic and effective in reducing <i>S.</i> Typhi bacteremia in children 9 months to 16 years of age. (Funded by the Bill and Melinda Gates Foundation; Current Controlled Trials number, ISRCTN43385161.).